XPEL Q1 2026 Earnings Modest EPS Beat Amid Quiet Revenue Disclosure Processa Pharmaceuticals PCSA Q4 2025 Earnings EPS Misses Estimates by a Wide Margin as PreRevenue Biotech Advances Pipeline PLTK Q1 2026 Earnings EPS Misses Estimates by 5181 Amid Challenging Quarter SLRC Q1 2026 Earnings Investment Income Misses Expectations as Stock Declines EPR Properties Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain OSR Holdings Q4 2025 Earnings EPS Misses Estimates Amidst Weak Market Sentiment